Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
Oslo, Norway, 24 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its first quarter 2018 results on Thursday, 3 May 2018. A presentation by Targovax's management to investors, analysts and the press will take place in Oslo at 10:00 CET. The results report and the presentation will be available at www.targovax.com in the Investors section from 07:00 CET. PresentationThe presentation will take place at 10:00 CET at: Hotel ContinentalStortingsgaten 24/260117 Oslo The